References
- Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314(8):488–500
Reference
- Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women. Proceedings of the National Heart Lung and Blood Institute Conference, January 22–24. Greenwich, Conn: Le Jacq Communications, 1993
- Steingart RM, Packer M, Hamm P, et al, for the Survival and Ventricular Enlargement Investigators. Sex differences in the ment of coronary artery disease. N Engl J Med 1991; 325(4):226–30
- Tofler GH, Stone PH, Muller JE, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol 1987: 9(3):473–82
- Manson JE, Stampfer MJ, Colditz GA, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991; 266(4):521–7
- Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247(12): 1707–14
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2(8607):349–60
- Gruppo Italiano per lo Studio della Strep-tochinasi nell'Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987; 2(8564):871–4
- Fisher LD, Kennedy JW, Davis KB, et al. Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg 1982;84(3):334–41
- Davis KB, Chaitman B, Ryan T, et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. J Am Coll Cardiol 1995; 25(5): 1000–9
- Cowley MJ, Mullin SM, Kelsey SF, et al. Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. Circulation 1985; 71(1):90–7
- Eaker ED, Castelli WP. Coronary heart disease and risk factors among women in the Framingham Study. In: Eaker ED, Packard B, Wenger NK, et al, eds. Coronary heart disease in women: proceedings of an NIH workshop. New York: Haymarket Doyma, 1987: 22–8
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Summary of the second report of the National Cholesterol Education Program (NCEP). JAMA 1993; 269(23):3015–23
- Shapiro AP, Rutan GH. Hypertension in women: differences and implications. In: Eaker ED, Packard B, Wenger NK, et al, eds. Coronary heart disease in women: proceedings of an NIH workshop. New York: Haymarket Doyma, 1987: 172–6
- Rosenberg L, Kaufman DW, Helm rich SP, et al. Myocardial infarction and cigarette smoking in women younger than 50 years of age. JAMA 1985; 253(20):2965–9
- Mann JI, Inman WH. Oral contraceptives and death from myocardial infarction. BMJ 1975; 2(5965): 245–8
- Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112(2): 432–7
- Kannel WB. High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am J Cardiol 1992; 71:631–9
- Pan WH, Cedres LB, Liu K, et al. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123(3):504–16
- Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67(5):968–77
- Gordon T, Kannel WB, Hjordand MC, et al. Menopause and coronary heart disease: the Framingham Study. Ann Intern Med 1978; 89(2): 157–61
- Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987:316(18): 105–10
- Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325(11):756–62
- Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ 1988:297(6647): 519–22
- Walsh BW, Schiff I, Rosner B, et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991: 325(17): 1196–204
- The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273(3):199–208